跳至主要内容
临床试验/jRCT2022210040
jRCT2022210040进行中(未招募)不适用

Pilot study of dMD-002 - A study on the efficacy and safety of dMD-002 in patients with neurovascular bundles injury during radical prostatectomy -

Mochida Pharmaceutical Co., Ltd.0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized Controlled Trial
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
20age old over 至 75age old not(—)
性别
Male

入选标准

  • (1) Patients diagnosed with prostate cancer
  • (2) Patients scheduled for radical prostatectomy (non-nerve sparing or unilateral nerve-sparing) by robot-assisted laparoscopic surgery

排除标准

  • (1) Patients required radiation therapy, endocrine therapy or antineoplastic therapy before or after radical prostatectomy
  • (2) Patients taking PDE5 inhibitors
  • (3) Patients using negative pressure erection apparatus

研究者

相似试验

Pilot study of dMD-002 in patients with... | 临床试验